Wealth Enhancement Advisory Services LLC Invests $77,000 in Definitive Healthcare Corp. $DH

Wealth Enhancement Advisory Services LLC purchased a new position in Definitive Healthcare Corp. (NASDAQ:DHFree Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 19,216 shares of the company’s stock, valued at approximately $77,000.

A number of other institutional investors have also recently made changes to their positions in DH. Hsbc Holdings PLC purchased a new position in Definitive Healthcare during the first quarter worth approximately $52,000. Cerity Partners LLC purchased a new position in Definitive Healthcare during the first quarter worth approximately $56,000. Petrus Trust Company LTA purchased a new position in Definitive Healthcare during the first quarter worth approximately $72,000. Meeder Asset Management Inc. purchased a new position in Definitive Healthcare during the first quarter worth approximately $76,000. Finally, Martingale Asset Management L P purchased a new position in Definitive Healthcare during the first quarter worth approximately $87,000. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Price Performance

NASDAQ:DH opened at $2.87 on Monday. Definitive Healthcare Corp. has a 52 week low of $2.15 and a 52 week high of $5.68. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $410.81 million, a P/E ratio of -1.08 and a beta of 1.65. The stock’s fifty day moving average is $3.86 and its two-hundred day moving average is $3.53.

Wall Street Analysts Forecast Growth

DH has been the topic of a number of analyst reports. Stifel Nicolaus lifted their price objective on Definitive Healthcare from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Friday, August 8th. Robert W. Baird set a $4.00 price objective on Definitive Healthcare in a research report on Friday, August 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, October 8th. Finally, Wall Street Zen upgraded Definitive Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, June 21st. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Reduce” and a consensus price target of $4.28.

View Our Latest Report on Definitive Healthcare

Definitive Healthcare Company Profile

(Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Articles

Want to see what other hedge funds are holding DH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Definitive Healthcare Corp. (NASDAQ:DHFree Report).

Institutional Ownership by Quarter for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.